| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |